IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v16y2025i1d10.1038_s41467-025-64261-w.html
   My bibliography  Save this article

Bacterial sexually transmitted infections and related antibiotic use among individuals eligible for doxycycline post-exposure prophylaxis in the United States

Author

Listed:
  • Anna M. Parker

    (University of California, Berkeley)

  • Jennifer J. Chang

    (Southern California Permanente Medical Group)

  • Ligong Chen

    (Perisphere Real World Evidence)

  • Laura M. King

    (University of California, Berkeley)

  • Sandra I. McCoy

    (University of California, Berkeley
    Gilead Sciences, Inc.)

  • Joseph A. Lewnard

    (University of California, Berkeley
    University of California, Berkeley
    University of California, Berkeley)

  • Katia J. Bruxvoort

    (University of Alabama at Birmingham)

Abstract

While doxycycline postexposure prophylaxis (doxyPEP) can prevent bacterial sexually transmitted infections (STIs), concern surrounds the volume of antibiotic use needed to realize this benefit. We estimated incidence rates of gonorrhea, chlamydia, and syphilis diagnoses and related antibiotic prescribing among US males and transgender individuals using Merative MarketScan® Research Databases during 2017-2019. Follow-up encompassed 38,543 person-years among recipients of HIV pre-exposure prophylaxis (PrEP), 29,228 person-years among people living with HIV (PLWH), and 19,918 person-years among people with prior-year STI diagnoses. Incidence rates of STI diagnoses among PLWH and PrEP recipients with ≥1 prior-year STI diagnosis totaled 33.3-35.5 per 100 person-years. Direct effects of doxyPEP could prevent 7.4-9.6 gonorrhea diagnoses, 7.3-8.1 chlamydia diagnoses, and 3.1-5.9 syphilis diagnoses per 100 person-years of use. However, expected increases in tetracycline consumption resulting from doxyPEP implementation totaled 271.9-312.9 additional 7-day doxycycline treatment courses per 100 person-years of use. These increases corresponded to 37.0-38.7, 36.5-37.0, and 46.1-100.2 additional 7-day doxycycline treatment courses for each prevented gonorrhea, chlamydia, and syphilis diagnosis, respectively. Increases in doxycycline use exceeded anticipated reductions in STI-related prescribing of cephalosporins, macrolides, and penicillins by 16–69-fold margins. Anticipated changes in antibiotic use as well as STI incidence should inform priority-setting for doxyPEP.

Suggested Citation

  • Anna M. Parker & Jennifer J. Chang & Ligong Chen & Laura M. King & Sandra I. McCoy & Joseph A. Lewnard & Katia J. Bruxvoort, 2025. "Bacterial sexually transmitted infections and related antibiotic use among individuals eligible for doxycycline post-exposure prophylaxis in the United States," Nature Communications, Nature, vol. 16(1), pages 1-13, December.
    • Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-64261-w
    DOI: 10.1038/s41467-025-64261-w
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-025-64261-w
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-025-64261-w?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Rupa R Patel & Leandro Mena & Amy Nunn & Timothy McBride & Laura C Harrison & Catherine E Oldenburg & Jingxia Liu & Kenneth H Mayer & Philip A Chan, 2017. "Impact of insurance coverage on utilization of pre-exposure prophylaxis for HIV prevention," PLOS ONE, Public Library of Science, vol. 12(5), pages 1-7, May.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Salabarría-Peña, Yamir & Douglas, Chelsea & Brantley, Meredith & Johnson, Amy K., 2022. "Informing the future of PrEP navigation: Findings from a five-site cluster evaluation," Evaluation and Program Planning, Elsevier, vol. 90(C).
    2. Carter, Jarvis W. & Salabarría-Peña, Yamir & Fields, Errol L. & Robinson, William T., 2022. "Evaluating for health equity among a cluster of health departments implementing PrEP services," Evaluation and Program Planning, Elsevier, vol. 90(C).

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-64261-w. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.